As far as I know, the 42 consecutive quarters of growth and profit were all from salvage treatment sales.
There have only been a few small test cases of frontline treatment (hence the need for SIRFLOX)
Share price obviously reflects market expectations of front line treatment
note the market is irrational and emotional at these times, which is also where opportunities are, whether you are long or short...
Clinical Trial Objectives, page-13
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)